Talampanel for Amyotrophic Lateral Sclerosis
- Study Title
- Talampanel for Amyotrophic Lateral Sclerosis (ALS)
- Teva Identifier
- ALS-TAL-201 (ALSTAR) | ALSTAR
- ClinicalTrials.gov Identifier
- NCT00696332
- Study Status
- Completed
- Trial Condition(s)
- ALS
- Interventions
- Drug: Talampanel | Other: placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 80 Years
- Trial Duration
- 09/01/2008 - 05/01/2010
- Phase
- Phase 2
